Sept 9 (Reuters) - NOVARTIS AG: * TO ACQUIRE TOURMALINE BIO, COMPLEMENTING CARDIOVASCULAR PIPELINE WITH PACIBEKITUG FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) * OFFER PRICE USD 48 PER SHARE, COMPANY VALUED AT USD 1.4BN * EXPECTS TO MERGE ACQUIRING SUBSIDIARY WITH AND INTO TOURMALINE * TRANSACTION IS EXPECTED TO CLOSE IN Q4 OF 2025 Source text: Further company...

BERLIN, Sept 9 (Reuters) - Switzerland's Novartis will acquire Tourmaline Bio ( TRML ) with an offer price of $48 per share, in a deal valuing the New York-based company at $1.4 billion on a fully diluted basis, it said on Tuesday. Novartis said it expected the deal to close in the fourth quarter and for Tourmaline to become an...

AMSTERDAM, Sept 9 (Reuters) - French artificial intelligence startup Mistral AI has raised 1.7 billion euros ($2 billion) in its latest funding round led by Dutch chip equipment maker ASML, the companies said on Tuesday, confirming a Reuters report from Sunday. ASML is investing 1.3 billion euros in Mistral AI as part of a series C funding round, making it...

World (CRYPTO: WLD) token defied gravity on Monday after a Nasdaq-listed firm embraced it as its primary treasury reserve asset. WLD Token Lifts Crypto Market WLD, the native currency of the Sam Altman-founded identity verification project, boomed nearly 48% in the last 24 hours, becoming the second-highest gainer among coins with a market value greater than $1 billion. The coin...